Sera Prognostics Announces Publication Of New Subgroup Analysis From PRIME Randomized Controlled Trial, Highlighting Screening Efficiency And Potential Cost Savings In Large Underserved Population

Loading news article.

Sera Prognostics Announces Publication Of New Subgroup Analysis From PRIME Randomized Controlled Trial, Highlighting Screening Efficiency And Potential Cost Savings In Large Underserved Population | WAPE

Sera Prognostics Announces Publication Of New Subgroup Analysis From PRIME Randomized Controlled Trial, Highlighting Screening Efficiency And Potential Cost Savings In Large Underserved Population

Article summary

Related companies

Comments —